NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
N/A (NSE: PHARMABEES)
PHARMABEES Technical Analysis
4
As on 28th Apr 2025 PHARMABEES SHARE Price closed @ 22.32 and we RECOMMEND Buy for LONG-TERM with Stoploss of 22.02 & Strong Buy for SHORT-TERM with Stoploss of 21.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHARMABEESSHARE Price
Open | 22.20 | Change | Price | % |
High | 22.40 | 1 Day | 0.43 | 1.96 |
Low | 21.31 | 1 Week | 0.56 | 2.57 |
Close | 22.32 | 1 Month | 0.79 | 3.67 |
Volume | 3022734 | 1 Year | 3.04 | 15.77 |
52 Week High 23.74 | 52 Week Low 11.74 |
NSE N/A Most Active Stocks
NSE N/A Top Gainers Stocks
JAYNECOIND | 42.37 | 19.99% |
PREMEXPLN | 438.50 | 13.29% |
ORIENTALTL | 10.30 | 12.81% |
BARBEQUE | 306.65 | 10.41% |
RBLBANK | 207.10 | 10.11% |
SECMARK | 115.67 | 9.99% |
COUNCODOS | 11.92 | 9.96% |
CCCL | 15.25 | 9.95% |
LFIC | 223.60 | 9.82% |
DCBBANK | 139.45 | 9.78% |
NSE N/A Top Losers Stocks
LLOYDSENGG | 59.38 | -16.99% |
TEJASNET | 747.85 | -12.93% |
ASALCBR | 1133.90 | -11.98% |
SMLISUZU | 1596.10 | -10.00% |
REFEX | 433.25 | -9.31% |
REPRO | 501.70 | -8.67% |
KAMATHOTEL | 245.40 | -8.65% |
SKYGOLD | 309.30 | -7.24% |
INDSWFTLAB | 75.30 | -6.47% |
BUTTERFLY | 658.75 | -5.95% |
PHARMABEES Daily Charts |
PHARMABEES Intraday Charts |
Whats New @ Bazaartrend |
PHARMABEES Free Analysis |
|
PHARMABEES Important Levels Intraday
RESISTANCE | 24.42 |
RESISTANCE | 23.75 |
RESISTANCE | 23.33 |
RESISTANCE | 22.91 |
SUPPORT | 21.73 |
SUPPORT | 21.31 |
SUPPORT | 20.89 |
SUPPORT | 20.22 |
PHARMABEES Target April 2025
4th UP Target | 26.54 |
3rd UP Target | 24.51 |
2nd UP Target | 23.26 |
1st UP Target | 22.01 |
1st DOWN Target | 18.43 |
2nd DOWN Target | 17.18 |
3rd DOWN Target | 15.93 |
4th DOWN Target | 13.9 |
PHARMABEES Weekly Target
4th UP Target | 23.89 |
3rd UP Target | 23.25 |
2nd UP Target | 22.85 |
1st UP Target | 22.46 |
1st DOWN Target | 21.32 |
2nd DOWN Target | 20.93 |
3rd DOWN Target | 20.53 |
4th DOWN Target | 19.89 |
PHARMABEES Target2025
4th UP Target | 43.26 |
3rd UP Target | 37.03 |
2nd UP Target | 33.18 |
1st UP Target | 29.33 |
1st DOWN Target | 18.35 |
2nd DOWN Target | 14.5 |
3rd DOWN Target | 10.65 |
4th DOWN Target | 4.42 |
N/A ( NSE N/A Symbol : PHARMABEES )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
PHARMABEES Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
PHARMABEES Other Details
Segment | N/A | |
Market Capital | N/A | |
Sector | N/A | |
Industry | N/A | |
Offical website | > echo $website ; ?> |
PHARMABEES Address
![]() |
N/A |
PHARMABEES Latest News
PHARMABEES Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service